These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10968275)

  • 1. Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt1 and MT2 receptors.
    Pégurier C; Curtet S; Nicolas JP; Boutin JA; Delagrange P; Renard P; Langlois M
    Bioorg Med Chem; 2000 Jan; 8(1):163-71. PubMed ID: 10968275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of new arylalkoxy amido derivatives as melatoninergic ligands.
    Pégurier C; Morellato L; Chahed E; Andrieux J; Nicolas JP; Boutin JA; Bennejean C; Delagrange P; Langlois M; Mathé-Allainmat M
    Bioorg Med Chem; 2003 Mar; 11(5):789-800. PubMed ID: 12538010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.
    Jellimann C; Mathé-Allainmat M; Andrieux J; Kloubert S; Boutin JA; Nicolas JP; Bennejean C; Delagrange P; Langlois M
    J Med Chem; 2000 Nov; 43(22):4051-62. PubMed ID: 11063602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of benzocycloalkane derivatives as new conformationally restricted ligands for melatonin receptors.
    Kloubert S; Mathé-Allainmat M; Andrieux J; Sicsic S; Langlois M
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3325-30. PubMed ID: 9873728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of ligand binding on melatonin receptor using non-peptide combinatorial libraries.
    Boutin JA; Lahaye C; Pegurier C; Nicolas JP; Fauchere JL; Langlois M; Renard P; Delagrange P; Canet E
    J Recept Signal Transduct Res; 2000 Jan; 20(1):105-18. PubMed ID: 10711500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
    Mathé-Allainmat M; Gaudy F; Sicsic S; Dangy-Caye AL; Shen S; Brémont B; Benatalah Z; Langlois M; Renard P; Delagrange P
    J Med Chem; 1996 Aug; 39(16):3089-95. PubMed ID: 8759629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.
    Nonno R; Pannacci M; Lucini V; Angeloni D; Fraschini F; Stankov BM
    Br J Pharmacol; 1999 Jul; 127(5):1288-94. PubMed ID: 10455277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of beta-substituted naphth-1-yl ethylamido derivatives as new melatoninergic agonists.
    Mathé-Allainmat M; Le Gall M; Jellimann C; Andrieux J; Langlois M
    Bioorg Med Chem; 1999 Dec; 7(12):2945-52. PubMed ID: 10658600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological analysis of high affinity melatonin receptor ligands.
    Chu GH; Witt-Enderby PA; Jones M; Pui-Kai L
    Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):272-5. PubMed ID: 11848222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
    Carocci A; Catalano A; Lovece A; Lentini G; Duranti A; Lucini V; Pannacci M; Scaglione F; Franchini C
    Bioorg Med Chem; 2010 Sep; 18(17):6496-511. PubMed ID: 20674373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands.
    Yous S; Durieux-Poissonnier S; Lipka-Belloli E; Guelzim H; Bochu C; Audinot V; Boutin JA; Delagrange P; Bennejean C; Renard P; Lesieur D
    Bioorg Med Chem; 2003 Mar; 11(5):753-9. PubMed ID: 12538005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular determinants for the differential coupling of Galpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors.
    Lai FP; Mody SM; Yung LY; Kam JY; Pang CS; Pang SF; Wong YH
    J Neurochem; 2002 Mar; 80(5):736-45. PubMed ID: 11948236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a high-affinity ligand that binds irreversibly to Mel1b melatonin receptors.
    Witt-Enderby PA; Chu GH; Gillen ML; Li PK
    J Med Chem; 1997 Dec; 40(26):4195-8. PubMed ID: 9435890
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.
    Leclerc V; Fourmaintraux E; Depreux P; Lesieur D; Morgan P; Howell HE; Renard P; Caignard DH; Pfeiffer B; Delagrange P; Guardiola-Lemaître B; Andrieux J
    Bioorg Med Chem; 1998 Oct; 6(10):1875-87. PubMed ID: 9839017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for the evaluation of drug action at the human melatonin receptor subtypes.
    Nonno R; Fraschini F; Stankov BM
    Biol Signals Recept; 1999; 8(1-2):32-40. PubMed ID: 10085460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
    Jellimann C; Mathé-Allainmat M; Andrieux J; Renard P; Delagrange P; Langlois M
    J Med Chem; 1999 Mar; 42(6):1100-5. PubMed ID: 10090792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the melatonin receptor. 4. Comparison of the binding affinities of a series of substituted phenylalkyl amides.
    Garratt PJ; Travard S; Vonhoff S; Tsotinis A; Sugden D
    J Med Chem; 1996 Apr; 39(9):1797-805. PubMed ID: 8627603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).
    Leclerc V; Yous S; Delagrange P; Boutin JA; Renard P; Lesieur D
    J Med Chem; 2002 Apr; 45(9):1853-9. PubMed ID: 11960497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
    Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
    Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands.
    Mor M; Spadoni G; Di Giacomo B; Diamantini G; Bedini A; Tarzia G; Plazzi PV; Rivara S; Nonno R; Lucini V; Pannacci M; Fraschini F; Stankov BM
    Bioorg Med Chem; 2001 Apr; 9(4):1045-57. PubMed ID: 11354661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.